Fml

Product manufactured by Allergan, Inc.

Application Nr Approved Date Route Status External Links
NDA016851 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Fml Suspension Is Indicated For The Treatment Of Corticosteroid-Responsive Inflammation Of The Palpebral And Bulbar Conjunctiva, Cornea And Anterior Segment Of The Globe.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Fluorometholone FLUOROMETHOLONE ZINC4213357

Comments